Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Liver Neoplasms | 15 | 2024 | 4319 | 0.810 |
Why?
|
Carcinoma, Hepatocellular | 10 | 2024 | 2297 | 0.710 |
Why?
|
Liver Cirrhosis | 17 | 2024 | 1934 | 0.650 |
Why?
|
Liver | 22 | 2024 | 7531 | 0.570 |
Why?
|
Elasticity Imaging Techniques | 6 | 2021 | 390 | 0.520 |
Why?
|
Fibroblast Growth Factors | 4 | 2024 | 867 | 0.420 |
Why?
|
Esophageal Diseases | 2 | 2004 | 169 | 0.420 |
Why?
|
Hepatitis C, Chronic | 7 | 2014 | 1032 | 0.420 |
Why?
|
Hepatitis B virus | 2 | 2016 | 528 | 0.410 |
Why?
|
Hepatic Stellate Cells | 3 | 2024 | 119 | 0.360 |
Why?
|
Choline Deficiency | 2 | 2019 | 23 | 0.290 |
Why?
|
Cholangiocarcinoma | 2 | 2021 | 552 | 0.280 |
Why?
|
Hepatitis B | 1 | 2012 | 706 | 0.270 |
Why?
|
Yttrium Radioisotopes | 2 | 2024 | 107 | 0.260 |
Why?
|
Hepacivirus | 2 | 2012 | 1337 | 0.250 |
Why?
|
Methionine | 2 | 2019 | 572 | 0.240 |
Why?
|
Hepatitis B, Chronic | 3 | 2016 | 410 | 0.240 |
Why?
|
Common Bile Duct Diseases | 1 | 2004 | 36 | 0.230 |
Why?
|
MAP Kinase Kinase Kinase 5 | 1 | 2024 | 20 | 0.230 |
Why?
|
Carcinoma, Verrucous | 1 | 2003 | 27 | 0.220 |
Why?
|
Microspheres | 2 | 2024 | 787 | 0.220 |
Why?
|
Liver Transplantation | 4 | 2024 | 2332 | 0.220 |
Why?
|
Fatty Liver | 4 | 2024 | 782 | 0.210 |
Why?
|
Alanine Transaminase | 3 | 2012 | 606 | 0.210 |
Why?
|
Keratin-18 | 2 | 2015 | 38 | 0.210 |
Why?
|
Hepatitis, Alcoholic | 1 | 2024 | 109 | 0.210 |
Why?
|
Granuloma | 1 | 2004 | 327 | 0.190 |
Why?
|
Endoscopy, Gastrointestinal | 3 | 2018 | 871 | 0.190 |
Why?
|
Hepatocytes | 3 | 2024 | 1232 | 0.180 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2024 | 687 | 0.180 |
Why?
|
Cilia | 1 | 2024 | 494 | 0.180 |
Why?
|
Kupffer Cells | 2 | 2000 | 143 | 0.170 |
Why?
|
Disease Models, Animal | 8 | 2024 | 18216 | 0.170 |
Why?
|
Graft Rejection | 3 | 2024 | 4438 | 0.170 |
Why?
|
Liver Cirrhosis, Experimental | 1 | 2019 | 29 | 0.170 |
Why?
|
Ethanol | 3 | 2024 | 1324 | 0.170 |
Why?
|
Cysts | 1 | 2024 | 681 | 0.160 |
Why?
|
Mice, Inbred BALB C | 3 | 2024 | 6206 | 0.160 |
Why?
|
Receptors, Aryl Hydrocarbon | 1 | 2020 | 220 | 0.150 |
Why?
|
Hepatitis, Autoimmune | 1 | 2020 | 172 | 0.150 |
Why?
|
Ampulla of Vater | 1 | 2018 | 149 | 0.150 |
Why?
|
Mice, Inbred C57BL | 9 | 2024 | 22121 | 0.150 |
Why?
|
Apyrase | 1 | 2020 | 373 | 0.150 |
Why?
|
Reperfusion Injury | 1 | 2024 | 1023 | 0.140 |
Why?
|
Esophagus | 1 | 2003 | 1030 | 0.140 |
Why?
|
Ventriculoperitoneal Shunt | 1 | 1998 | 188 | 0.140 |
Why?
|
Biopsy | 10 | 2021 | 6765 | 0.140 |
Why?
|
Cyclic AMP-Dependent Protein Kinase Catalytic Subunits | 1 | 2016 | 12 | 0.130 |
Why?
|
Hepatitis B Core Antigens | 1 | 2016 | 90 | 0.130 |
Why?
|
HSP40 Heat-Shock Proteins | 1 | 2016 | 82 | 0.130 |
Why?
|
Bile Duct Neoplasms | 1 | 2021 | 605 | 0.130 |
Why?
|
Mice, Knockout | 6 | 2024 | 14397 | 0.130 |
Why?
|
Disease Progression | 6 | 2024 | 13484 | 0.130 |
Why?
|
Monocytes | 1 | 2024 | 2572 | 0.120 |
Why?
|
Catheterization, Central Venous | 1 | 2000 | 527 | 0.120 |
Why?
|
Hypertension, Portal | 2 | 2014 | 226 | 0.120 |
Why?
|
Hepatitis B Surface Antigens | 1 | 2016 | 301 | 0.120 |
Why?
|
Salivary Glands, Minor | 1 | 1994 | 25 | 0.120 |
Why?
|
Adenocarcinoma | 4 | 2012 | 6330 | 0.120 |
Why?
|
Carcinoma | 2 | 1998 | 2328 | 0.120 |
Why?
|
Forefoot, Human | 1 | 1994 | 31 | 0.120 |
Why?
|
Ischemia | 1 | 2003 | 1876 | 0.120 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2020 | 1135 | 0.120 |
Why?
|
Ethiodized Oil | 1 | 1993 | 26 | 0.110 |
Why?
|
Gelatin Sponge, Absorbable | 1 | 1993 | 55 | 0.110 |
Why?
|
Th17 Cells | 1 | 2020 | 792 | 0.110 |
Why?
|
Histocytochemistry | 1 | 2014 | 698 | 0.110 |
Why?
|
Fats | 1 | 2014 | 99 | 0.110 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2020 | 3072 | 0.110 |
Why?
|
Foot Diseases | 1 | 1994 | 147 | 0.110 |
Why?
|
Cholangitis, Sclerosing | 1 | 2014 | 177 | 0.100 |
Why?
|
Chemoembolization, Therapeutic | 1 | 1993 | 128 | 0.100 |
Why?
|
Isoantibodies | 1 | 2016 | 674 | 0.100 |
Why?
|
Hyaluronic Acid | 3 | 2010 | 482 | 0.100 |
Why?
|
Phosphatidate Phosphatase | 1 | 2011 | 20 | 0.100 |
Why?
|
Hydrocephalus | 1 | 1998 | 764 | 0.100 |
Why?
|
Hepatitis, Chronic | 1 | 2011 | 52 | 0.100 |
Why?
|
Crohn Disease | 1 | 2004 | 2278 | 0.100 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2003 | 2016 | 0.090 |
Why?
|
Doxorubicin | 2 | 1997 | 2215 | 0.090 |
Why?
|
Axilla | 1 | 1993 | 624 | 0.090 |
Why?
|
Clinical Enzyme Tests | 1 | 2010 | 115 | 0.090 |
Why?
|
Salivary Gland Neoplasms | 1 | 1994 | 304 | 0.090 |
Why?
|
Esophagogastric Junction | 1 | 2012 | 343 | 0.090 |
Why?
|
Epinephrine | 1 | 1993 | 792 | 0.090 |
Why?
|
Cell Proliferation | 3 | 2022 | 10425 | 0.090 |
Why?
|
Lipogenesis | 1 | 2011 | 210 | 0.080 |
Why?
|
Male | 37 | 2024 | 360035 | 0.080 |
Why?
|
Leiomyoma | 1 | 1994 | 636 | 0.080 |
Why?
|
Meningeal Neoplasms | 1 | 1998 | 1248 | 0.080 |
Why?
|
Aspartate Aminotransferases | 1 | 2010 | 417 | 0.080 |
Why?
|
Endothelium, Vascular | 2 | 2004 | 4430 | 0.080 |
Why?
|
ROC Curve | 5 | 2016 | 3571 | 0.080 |
Why?
|
Endosonography | 1 | 2012 | 609 | 0.080 |
Why?
|
Humans | 48 | 2024 | 760437 | 0.080 |
Why?
|
Middle Aged | 27 | 2024 | 220382 | 0.080 |
Why?
|
Predictive Value of Tests | 7 | 2018 | 15257 | 0.070 |
Why?
|
Triiodothyronine | 1 | 2009 | 493 | 0.070 |
Why?
|
Biopsy, Needle | 3 | 2006 | 1626 | 0.070 |
Why?
|
Intestinal Mucosa | 1 | 2018 | 3026 | 0.070 |
Why?
|
Diagnosis, Differential | 6 | 2006 | 12969 | 0.070 |
Why?
|
Bile Ducts | 2 | 2006 | 282 | 0.070 |
Why?
|
Female | 30 | 2024 | 391875 | 0.070 |
Why?
|
Fatty Acids | 1 | 2014 | 1805 | 0.070 |
Why?
|
Animals | 18 | 2024 | 168253 | 0.070 |
Why?
|
Thrombosis | 1 | 2000 | 2940 | 0.070 |
Why?
|
Mice | 13 | 2024 | 81402 | 0.070 |
Why?
|
Liver Diseases | 2 | 2024 | 1296 | 0.060 |
Why?
|
Palliative Care | 2 | 1998 | 3585 | 0.060 |
Why?
|
Lymphatic Metastasis | 1 | 1993 | 2912 | 0.060 |
Why?
|
Obesity | 4 | 2021 | 12918 | 0.060 |
Why?
|
Inflammation | 2 | 2007 | 10746 | 0.060 |
Why?
|
Soft Tissue Neoplasms | 1 | 1994 | 1154 | 0.060 |
Why?
|
Transforming Growth Factor beta | 1 | 2012 | 1959 | 0.060 |
Why?
|
Thioacetamide | 1 | 2024 | 22 | 0.060 |
Why?
|
Adult | 23 | 2024 | 220781 | 0.060 |
Why?
|
Indenes | 1 | 2024 | 58 | 0.060 |
Why?
|
Immunohistochemistry | 4 | 2016 | 11070 | 0.060 |
Why?
|
Biliary Tract | 1 | 2024 | 135 | 0.060 |
Why?
|
Furans | 1 | 2024 | 200 | 0.050 |
Why?
|
Lactates | 1 | 2024 | 404 | 0.050 |
Why?
|
Collagen Type I | 2 | 2019 | 616 | 0.050 |
Why?
|
Pyruvic Acid | 1 | 2024 | 203 | 0.050 |
Why?
|
Vacuoles | 1 | 2003 | 228 | 0.050 |
Why?
|
Rats, Inbred F344 | 1 | 2024 | 825 | 0.050 |
Why?
|
Phosphofructokinase-2 | 1 | 2022 | 32 | 0.050 |
Why?
|
Docosahexaenoic Acids | 2 | 2006 | 908 | 0.050 |
Why?
|
RNA-Binding Proteins | 1 | 2011 | 1897 | 0.050 |
Why?
|
Esophageal Neoplasms | 1 | 2012 | 1646 | 0.050 |
Why?
|
Keratins | 1 | 2003 | 497 | 0.050 |
Why?
|
Pilonidal Sinus | 1 | 2001 | 16 | 0.050 |
Why?
|
Lymph Nodes | 1 | 1993 | 3469 | 0.050 |
Why?
|
Sulfones | 1 | 2024 | 447 | 0.050 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 2 | 2014 | 151 | 0.050 |
Why?
|
Condylomata Acuminata | 1 | 2001 | 75 | 0.050 |
Why?
|
Antigens, CD1 | 1 | 2004 | 439 | 0.050 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2004 | 431 | 0.050 |
Why?
|
Cell Size | 1 | 2003 | 624 | 0.050 |
Why?
|
Colonography, Computed Tomographic | 1 | 2003 | 170 | 0.050 |
Why?
|
Aged | 13 | 2024 | 168840 | 0.050 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2004 | 449 | 0.050 |
Why?
|
Vaginal Smears | 1 | 2003 | 499 | 0.040 |
Why?
|
Hepatectomy | 1 | 2024 | 558 | 0.040 |
Why?
|
Severity of Illness Index | 4 | 2014 | 15820 | 0.040 |
Why?
|
Anus Neoplasms | 1 | 2004 | 329 | 0.040 |
Why?
|
Lipids | 1 | 2011 | 3342 | 0.040 |
Why?
|
Arteriosclerosis | 1 | 2004 | 1055 | 0.040 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2021 | 296 | 0.040 |
Why?
|
Sterol Regulatory Element Binding Protein 2 | 1 | 2019 | 56 | 0.040 |
Why?
|
Animal Feed | 1 | 2019 | 113 | 0.040 |
Why?
|
Biphenyl Compounds | 1 | 2004 | 1003 | 0.040 |
Why?
|
Stearoyl-CoA Desaturase | 1 | 2019 | 85 | 0.040 |
Why?
|
Liver Neoplasms, Experimental | 1 | 2000 | 189 | 0.040 |
Why?
|
Benzimidazoles | 1 | 2004 | 855 | 0.040 |
Why?
|
Catheterization | 1 | 2004 | 1432 | 0.040 |
Why?
|
Vimentin | 1 | 2000 | 255 | 0.040 |
Why?
|
Cytoplasm | 1 | 2003 | 1511 | 0.040 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2012 | 4575 | 0.040 |
Why?
|
Phlebography | 1 | 2000 | 326 | 0.040 |
Why?
|
Necrosis | 1 | 2003 | 1604 | 0.040 |
Why?
|
Lymphocytosis | 1 | 1999 | 121 | 0.040 |
Why?
|
Tetrazoles | 1 | 2004 | 907 | 0.040 |
Why?
|
Aortic Diseases | 1 | 2004 | 737 | 0.040 |
Why?
|
Nerve Tissue Proteins | 1 | 2011 | 4413 | 0.040 |
Why?
|
Random Allocation | 2 | 2017 | 2388 | 0.040 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2006 | 1116 | 0.040 |
Why?
|
HIV Seropositivity | 1 | 2004 | 960 | 0.040 |
Why?
|
Glycolysis | 1 | 2022 | 832 | 0.040 |
Why?
|
Retrospective Studies | 8 | 2024 | 80430 | 0.040 |
Why?
|
Rats | 3 | 2024 | 23712 | 0.040 |
Why?
|
Catheters, Indwelling | 1 | 2000 | 427 | 0.040 |
Why?
|
Equipment Failure | 1 | 2000 | 578 | 0.040 |
Why?
|
Factor VIII | 1 | 2000 | 349 | 0.040 |
Why?
|
Fatty Liver, Alcoholic | 1 | 2017 | 36 | 0.040 |
Why?
|
Fibrin | 1 | 2000 | 505 | 0.040 |
Why?
|
Cystic Fibrosis | 1 | 2006 | 1284 | 0.040 |
Why?
|
Lactic Acid | 1 | 2022 | 1134 | 0.040 |
Why?
|
Gene Expression Regulation | 3 | 2011 | 11900 | 0.030 |
Why?
|
Aorta | 1 | 2004 | 2042 | 0.030 |
Why?
|
Sensitivity and Specificity | 4 | 2016 | 14661 | 0.030 |
Why?
|
Mice, Transgenic | 2 | 2024 | 9533 | 0.030 |
Why?
|
Immunomodulation | 1 | 2020 | 547 | 0.030 |
Why?
|
Diagnostic Errors | 1 | 2003 | 1264 | 0.030 |
Why?
|
T-Lymphocyte Subsets | 1 | 2004 | 1805 | 0.030 |
Why?
|
Embolization, Therapeutic | 1 | 2006 | 1418 | 0.030 |
Why?
|
Homosexuality, Male | 1 | 2004 | 1333 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 3 | 2014 | 20551 | 0.030 |
Why?
|
Colitis | 1 | 2004 | 1230 | 0.030 |
Why?
|
Liver Diseases, Alcoholic | 1 | 2017 | 156 | 0.030 |
Why?
|
Killer Cells, Natural | 1 | 2004 | 2202 | 0.030 |
Why?
|
Infusions, Subcutaneous | 1 | 2014 | 43 | 0.030 |
Why?
|
Sulfonamides | 1 | 2024 | 1973 | 0.030 |
Why?
|
Cell Nucleus | 1 | 2003 | 2906 | 0.030 |
Why?
|
Combined Modality Therapy | 2 | 1998 | 8522 | 0.030 |
Why?
|
Fibrosis | 1 | 2021 | 2048 | 0.030 |
Why?
|
Immunity, Cellular | 1 | 2020 | 1559 | 0.030 |
Why?
|
Reproducibility of Results | 3 | 2018 | 20078 | 0.030 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2015 | 239 | 0.030 |
Why?
|
Decision Trees | 1 | 2016 | 504 | 0.030 |
Why?
|
Hepatitis C | 1 | 2004 | 1583 | 0.030 |
Why?
|
Hematoxylin | 1 | 1993 | 60 | 0.030 |
Why?
|
Eosine Yellowish-(YS) | 1 | 1993 | 69 | 0.030 |
Why?
|
Antibiotics, Antineoplastic | 1 | 1997 | 677 | 0.030 |
Why?
|
DNA, Viral | 2 | 2016 | 2201 | 0.030 |
Why?
|
Lipid Peroxidation | 1 | 2014 | 271 | 0.030 |
Why?
|
Emulsions | 1 | 1993 | 153 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 3 | 1999 | 9267 | 0.030 |
Why?
|
Ligands | 1 | 2020 | 3270 | 0.030 |
Why?
|
Graft Survival | 1 | 2024 | 3806 | 0.030 |
Why?
|
Iopamidol | 1 | 1993 | 186 | 0.030 |
Why?
|
Research Report | 1 | 2016 | 367 | 0.030 |
Why?
|
Diabetic Nephropathies | 1 | 2000 | 973 | 0.030 |
Why?
|
Radiation Dosage | 1 | 2021 | 1958 | 0.030 |
Why?
|
Radiography, Interventional | 2 | 2006 | 1121 | 0.030 |
Why?
|
Matrix Metalloproteinase 1 | 1 | 2012 | 145 | 0.030 |
Why?
|
Hepatitis | 1 | 2014 | 229 | 0.030 |
Why?
|
Viral Core Proteins | 1 | 2012 | 161 | 0.030 |
Why?
|
Bronchoscopes | 1 | 2012 | 64 | 0.030 |
Why?
|
Drug Discovery | 1 | 2020 | 1054 | 0.030 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 1999 | 1373 | 0.020 |
Why?
|
Observer Variation | 1 | 2018 | 2604 | 0.020 |
Why?
|
Prospective Studies | 4 | 2021 | 54339 | 0.020 |
Why?
|
Carcinoma, Adenoid Cystic | 1 | 1994 | 262 | 0.020 |
Why?
|
Neutrophils | 1 | 2024 | 3764 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2003 | 3661 | 0.020 |
Why?
|
Area Under Curve | 1 | 2015 | 1633 | 0.020 |
Why?
|
Age Factors | 4 | 2009 | 18379 | 0.020 |
Why?
|
Up-Regulation | 1 | 2020 | 4116 | 0.020 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2014 | 613 | 0.020 |
Why?
|
Mice, Inbred ICR | 1 | 2011 | 364 | 0.020 |
Why?
|
Colorectal Neoplasms | 2 | 2003 | 6894 | 0.020 |
Why?
|
Interferon-gamma | 2 | 2012 | 3157 | 0.020 |
Why?
|
Mitochondria | 1 | 2024 | 3624 | 0.020 |
Why?
|
Renal Dialysis | 1 | 2000 | 1795 | 0.020 |
Why?
|
Breast Neoplasms | 2 | 1998 | 20985 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2021 | 2821 | 0.020 |
Why?
|
Muscle, Smooth | 1 | 1994 | 926 | 0.020 |
Why?
|
alpha-Macroglobulins | 1 | 2009 | 60 | 0.020 |
Why?
|
Macrophages | 1 | 2004 | 5764 | 0.020 |
Why?
|
Adenoma | 2 | 2003 | 2157 | 0.020 |
Why?
|
gamma-Glutamyltransferase | 1 | 2009 | 144 | 0.020 |
Why?
|
Incidence | 2 | 2000 | 21322 | 0.020 |
Why?
|
Microscopy, Video | 2 | 2000 | 242 | 0.020 |
Why?
|
Time Factors | 3 | 2019 | 39947 | 0.020 |
Why?
|
Injections, Intravenous | 2 | 2003 | 1379 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 3800 | 0.020 |
Why?
|
Esophageal and Gastric Varices | 1 | 2010 | 208 | 0.020 |
Why?
|
Colonic Neoplasms | 1 | 2000 | 2529 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2014 | 2227 | 0.020 |
Why?
|
Serum | 1 | 2009 | 210 | 0.020 |
Why?
|
Apoptosis | 1 | 2024 | 9468 | 0.020 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2016 | 1605 | 0.020 |
Why?
|
Receptors, Leptin | 1 | 2009 | 350 | 0.020 |
Why?
|
Iodide Peroxidase | 1 | 2009 | 294 | 0.020 |
Why?
|
Bilirubin | 1 | 2009 | 437 | 0.020 |
Why?
|
Administration, Oral | 2 | 2006 | 4010 | 0.020 |
Why?
|
Hepatitis B e Antigens | 1 | 2007 | 133 | 0.020 |
Why?
|
Mice, Inbred CFTR | 1 | 2006 | 18 | 0.020 |
Why?
|
Interleukin-10 | 1 | 2012 | 1176 | 0.020 |
Why?
|
Mice, Congenic | 1 | 2006 | 97 | 0.020 |
Why?
|
Lectins | 1 | 2009 | 491 | 0.020 |
Why?
|
Adipokines | 1 | 2009 | 310 | 0.020 |
Why?
|
Viral Load | 1 | 2016 | 3329 | 0.020 |
Why?
|
RNA Splicing | 1 | 2011 | 915 | 0.020 |
Why?
|
Deglutition Disorders | 1 | 2012 | 627 | 0.020 |
Why?
|
Ultrasonography | 2 | 2015 | 5966 | 0.020 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2001 | 4020 | 0.020 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1994 | 2199 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2014 | 1886 | 0.020 |
Why?
|
Heat-Shock Proteins | 1 | 2009 | 795 | 0.020 |
Why?
|
Salivary Glands | 1 | 2006 | 229 | 0.020 |
Why?
|
Arachidonic Acid | 1 | 2006 | 427 | 0.020 |
Why?
|
Neoplasm Transplantation | 2 | 2000 | 2014 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2014 | 6525 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2020 | 18955 | 0.010 |
Why?
|
Lung Diseases | 1 | 1994 | 1909 | 0.010 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily B | 1 | 2004 | 84 | 0.010 |
Why?
|
Acute Disease | 2 | 2006 | 7230 | 0.010 |
Why?
|
Ileum | 1 | 2006 | 557 | 0.010 |
Why?
|
Cholesterol, Dietary | 1 | 2004 | 224 | 0.010 |
Why?
|
Anus Diseases | 1 | 2004 | 55 | 0.010 |
Why?
|
Risk Assessment | 2 | 2009 | 23953 | 0.010 |
Why?
|
Treatment Outcome | 3 | 2024 | 64591 | 0.010 |
Why?
|
Rupture, Spontaneous | 1 | 2004 | 362 | 0.010 |
Why?
|
Antigens, CD1d | 1 | 2004 | 217 | 0.010 |
Why?
|
Antiviral Agents | 1 | 2016 | 3066 | 0.010 |
Why?
|
Dextran Sulfate | 1 | 2004 | 255 | 0.010 |
Why?
|
Hemorrhage | 1 | 1994 | 3414 | 0.010 |
Why?
|
Mice, Nude | 2 | 2000 | 3603 | 0.010 |
Why?
|
Radiography | 2 | 2009 | 6963 | 0.010 |
Why?
|
Interleukin-13 | 1 | 2004 | 375 | 0.010 |
Why?
|
Skin Neoplasms | 1 | 2001 | 5815 | 0.010 |
Why?
|
Models, Immunological | 1 | 2004 | 512 | 0.010 |
Why?
|
Child, Preschool | 1 | 2024 | 42209 | 0.010 |
Why?
|
Glycoproteins | 1 | 2009 | 2207 | 0.010 |
Why?
|
United States | 3 | 2016 | 72202 | 0.010 |
Why?
|
Polymerase Chain Reaction | 2 | 2001 | 6086 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 2 | 2024 | 36362 | 0.010 |
Why?
|
Tumor Cells, Cultured | 2 | 2000 | 6128 | 0.010 |
Why?
|
Lectins, C-Type | 1 | 2004 | 584 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2017 | 14565 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2015 | 12429 | 0.010 |
Why?
|
Alkaline Phosphatase | 1 | 2004 | 866 | 0.010 |
Why?
|
Survival Analysis | 1 | 1993 | 10075 | 0.010 |
Why?
|
Subtraction Technique | 1 | 2003 | 511 | 0.010 |
Why?
|
Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor | 1 | 1999 | 40 | 0.010 |
Why?
|
Prognosis | 2 | 2011 | 29551 | 0.010 |
Why?
|
Genomics | 1 | 2016 | 5806 | 0.010 |
Why?
|
Antigens, Surface | 1 | 2004 | 1608 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 1993 | 12054 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2016 | 8519 | 0.010 |
Why?
|
Gene Expression | 1 | 2012 | 7582 | 0.010 |
Why?
|
Pancreas | 1 | 2006 | 1684 | 0.010 |
Why?
|
Polymorphism, Single-Stranded Conformational | 1 | 1999 | 330 | 0.010 |
Why?
|
Survival Rate | 1 | 1993 | 12698 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2006 | 39078 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2004 | 1337 | 0.010 |
Why?
|
Exudates and Transudates | 1 | 1999 | 174 | 0.010 |
Why?
|
Th1 Cells | 1 | 2004 | 1037 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2014 | 12785 | 0.010 |
Why?
|
Homozygote | 1 | 2004 | 1794 | 0.010 |
Why?
|
Th2 Cells | 1 | 2004 | 1054 | 0.010 |
Why?
|
Antigen Presentation | 1 | 2004 | 1254 | 0.010 |
Why?
|
Radiographic Image Enhancement | 1 | 2003 | 876 | 0.010 |
Why?
|
Rabbits | 1 | 2004 | 4780 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 2001 | 1900 | 0.010 |
Why?
|
Young Adult | 1 | 2024 | 59068 | 0.010 |
Why?
|
Injections, Intra-Arterial | 1 | 1997 | 182 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2006 | 4808 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2007 | 2691 | 0.010 |
Why?
|
Boston | 1 | 2010 | 9326 | 0.010 |
Why?
|
Tail | 1 | 1997 | 92 | 0.010 |
Why?
|
Erythrocytes | 1 | 2006 | 2417 | 0.010 |
Why?
|
Heterozygote | 1 | 2004 | 2798 | 0.010 |
Why?
|
Signal Transduction | 1 | 2020 | 23397 | 0.010 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 1999 | 649 | 0.010 |
Why?
|
Mutation | 2 | 2016 | 30025 | 0.010 |
Why?
|
Hepatic Artery | 1 | 1997 | 232 | 0.010 |
Why?
|
Transfection | 1 | 2004 | 5776 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2011 | 4923 | 0.010 |
Why?
|
Child | 1 | 2024 | 80086 | 0.010 |
Why?
|
Adolescent | 1 | 2024 | 88196 | 0.010 |
Why?
|
Colon | 1 | 2004 | 1791 | 0.010 |
Why?
|
Cholesterol | 1 | 2004 | 2902 | 0.010 |
Why?
|
Insulin Resistance | 1 | 2009 | 3956 | 0.010 |
Why?
|
Sex Factors | 1 | 2009 | 10538 | 0.010 |
Why?
|
HIV Infections | 1 | 2001 | 17328 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2009 | 12127 | 0.010 |
Why?
|
Portal Vein | 1 | 1997 | 431 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2011 | 16945 | 0.010 |
Why?
|
Gene Rearrangement | 1 | 1999 | 1125 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 1998 | 13312 | 0.010 |
Why?
|
Liposomes | 1 | 1997 | 781 | 0.010 |
Why?
|
Lung | 2 | 2006 | 9973 | 0.010 |
Why?
|
Drug Carriers | 1 | 1997 | 706 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2000 | 6230 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2012 | 26063 | 0.010 |
Why?
|
Body Mass Index | 1 | 2009 | 12932 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 1997 | 2647 | 0.010 |
Why?
|
Cell Line | 1 | 2004 | 15598 | 0.010 |
Why?
|
Contrast Media | 1 | 2003 | 5310 | 0.010 |
Why?
|
Transcription Factors | 1 | 2009 | 12121 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2006 | 58859 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 1997 | 8163 | 0.000 |
Why?
|
Cohort Studies | 1 | 2007 | 41366 | 0.000 |
Why?
|
Risk Factors | 1 | 2009 | 74055 | 0.000 |
Why?
|